switching from semaglutide to tirzepatide for weight loss Switching from tirzepatide to semaglutide:

[29, 30, 31] Risk factors: Diabetes (especially in combination with SGLT2 inhibitors use) Reduced oral intake and severe GI symptoms Dehydration Presentation: Nausea, vomiting, abdominal pain Anion gap metabolic acidosis Elevated ketones Normal or mildly elevated glucose Key point: EDKA has not been observed in non-diabetic patients in large cohort data

Vitamin C works best when you use it correctly

10.1136/gutjnl-2013-305302 62

They also tend to show up in a DEXA scan rather than a mirror, which is why most women don't connect the symptoms to the weight loss until something more dramatic - a fracture from a minor fall, for example - forces the issue

GLP-1 agonists appear to enhance serotonin activity in certain brain pathways